Impact of gout on in-hospital outcomes of acute coronary syndrome-related hospitalizations and revascularizations: Insights from the national inpatient sample

doi:10.4330/wjc.v11.i5.137

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7930)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

591

WORD

178

HTML

4427

Tables (1-5)

238

Sum=5434

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

915

Download

1581

Sum=2496

May 26, 2019 (publication date) through Nov 6, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Cardiol. May 26, 2019; 11(5): 137-148
Published online May 26, 2019. doi: 10.4330/wjc.v11.i5.137

Table 5 Predictors of in-hospital mortality in acute coronary syndrome patients with gout undergoing revascularization

Predictor	Adjusted odds ratio	95%CI (LL-UL)	P value
Age in years at admission			< 0.001^a
45-64 vs 18-44	2.99	1.08-8.30	0.036^a
65-84 vs 18-44	5.72	2.04-16.01	0.001^a
≥ 85 vs 18-44	15.63	5.51-44.39	< 0.001^a
Male vs female	0.89	0.75-1.05	0.155
Race			< 0.001^a
African American vs white	1.09	0.88-1.35	0.413
Hispanic vs white	0.45	0.31-0.67	< 0.001^a
Asian vs white	0.65	0.45-0.94	0.022^a
Non-elective vs elective admission	2.00	1.44-2.79	< 0.001^a
Median household income quartile 0-25^thvs 76-100^th#	1.44	1.17-1.78	0.001^a
Comorbidities
Alcohol abuse	0.49	0.31-0.79	0.003^a
Rheumatoid arthritis/collagen vascular diseases	1.57	1.09-2.25	0.016^a
Congestive heart failure	5.91	3.54-9.86	0.000^a
Coagulopathy	1.29	1.05-1.58	0.014^a
Drug abuse	2.33	1.34-4.05	0.003^a
Fluid and electrolyte disorders	2.88	2.49-3.35	< 0.001^a
Other neurological disorders	1.72	1.33-2.23	< 0.001^a
Obesity	0.79	0.66-0.95	0.012^a
Peripheral vascular disorders	1.60	1.36-1.88	< 0.001^a
Renal failure	2.04	1.13-3.70	0.019^a
Valvular disease	8.15	3.87-17.15	< 0.001^a
Dyslipidemia	0.63	0.54-0.72	< 0.001^a
Outcomes/postoperative complications
Hypotension/shock	2.97	1.93-4.56	< 0.001^a
Cardiac complications	1.59	1.19-2.11	0.002^a
Postoperative myocardial infarction	2.53	1.74-3.68	< 0.001^a
Perioperative stroke	2.48	1.20-5.10	0.014^a
Respiratory complications	1.80	1.41-2.30	< 0.001^a
Postoperative acute kidney injury	1.48	1.26-1.74	< 0.001^a
Infections/septicemia	3.94	3.01-5.16	< 0.001^a

^aP < 0.05 indicates clinical significance. CI: Confidence interval; LL: Lower level; UL: Upper level, Multivariate regression model was adjusted for age, gender, race, admission type, median household income, payer status, hospital characteristics and all relevant comorbidities and prior medical history.

Citation: Desai R, Parekh T, Goyal H, Fong HK, Zalavadia D, Damarlapally N, Doshi R, Savani S, Kumar G, Sachdeva R. Impact of gout on in-hospital outcomes of acute coronary syndrome-related hospitalizations and revascularizations: Insights from the national inpatient sample. World J Cardiol 2019; 11(5): 137-148
URL: https://www.wjgnet.com/1949-8462/full/v11/i5/137.htm
DOI: https://dx.doi.org/10.4330/wjc.v11.i5.137